Biopolymer Innovations is a life science company specializing in the development of biodegradable, polysaccharide-based drug delivery systems. The first product under development, OcularGel, is a drug delivery system for topical ocular drugs (glaucoma, antibacterial and anti-inflammation treatments). The firm's second product is a biodegradable scaffold for anchoring and supporting liver cells to support liver function for patients with chronic and acute liver failure. A third product line is for delivery of drugs to target tissue in the posterior segment of the eye The company has a wide range of expertise including in the areas of bio-based materials, clinical ophthalmology, biomedical engineering, and small business management.
In the area of drug delivery, this product platform will allow for pharmaceutical companies to re-formulate their current products and apply for extended patent protection. This is a substantial cost reduction from discovering and developing a new pharmaceutical agent. These materials represent the first of a number of medical and drug delivery products that are to be characterized (discovered) and developed by Biopolymer Innovations.
